Literature DB >> 21959692

[Psoriasis arthritis. An interdisciplinary challenge].

M A Radtke1, K Reich, F Beikert, M Augustin.   

Abstract

Psoriatic arthritis (PsA) is classified as a spondylarthropathy based on its clinical and serological characteristics. The clinical manifestations and the association with psoriasis or nail psoriasis have led, together with immunological characteristics, to a further differentiation. The pathophysiological and genetic understanding of this disease has advanced as a result of the development of new treatment strategies and targets in rheumatology and dermatology. Collaborative efforts and increasing multidisciplinary cooperation between rheumatologists and dermatologists have led to an increased awareness in early diagnosis and treatment. New treatment modalities have demonstrated significant efficacy in preventing radiologic progression resulting in amelioration of clinical symptoms, improvement of function and quality of life.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959692     DOI: 10.1007/s00105-011-2243-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  19 in total

1.  Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.

Authors:  A Kavanaugh; G G Krueger; A Beutler; C Guzzo; B Zhou; L T Dooley; P J Mease; D D Gladman; K de Vlam; P P Geusens; C Birbara; D G Halter; C Antoni
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

2.  Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis.

Authors:  P Pasquetti; G Morozzi; M Galeazzi
Journal:  Rheumatology (Oxford)       Date:  2008-12-24       Impact factor: 7.580

Review 3.  Update on biomarkers in psoriatic arthritis.

Authors:  Vinod Chandran; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 4.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

5.  Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria.

Authors:  Laura Congi; Euthalia Roussou
Journal:  Clin Exp Rheumatol       Date:  2010-06-23       Impact factor: 4.473

Review 6.  Review of the use of ultrasound for the diagnosis and monitoring of enthesitis in psoriatic arthritis.

Authors:  Gurjit Singh Kaeley
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

Review 7.  Psoriatic arthritis: update on pathophysiology, assessment and management.

Authors:  Philip J Mease
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

Review 8.  Classification and diagnostic criteria for psoriatic arthritis.

Authors:  P S Helliwell; W J Taylor
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 9.  The enthesis organ concept and its relevance to the spondyloarthropathies.

Authors:  Michael Benjamin; Dennis McGonagle
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

View more
  1 in total

1.  Multispectral optoacoustic tomography might be a helpful tool for noninvasive early diagnosis of psoriatic arthritis.

Authors:  Sandra Hallasch; Nina Giese; Ingo Stoffels; Joachim Klode; Wiebke Sondermann
Journal:  Photoacoustics       Date:  2020-11-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.